Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kea Martin

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Frontiers in Immunology|October 21, 2015
Modulation of APC Function and Anti-Tumor Immunity by Anti-Cancer DrugsKea Martin, Jens Schreiner, Alfred Zippelius
Neurology(R) Neuroimmunology & Neuroinflammation|November 11, 2021
Decrease in Serum Anti-MAG Autoantibodies Is Associated With Therapy Response in Patients With Anti-MAG Neuropathy: Retrospective StudyPascal Hänggi, Butrint Aliu, Kea Martin, et al.
Oncoimmunology|January 23, 2015
Cancer chemotherapy agents target intratumoral dendritic cells to potentiate antitumor immunityPhilipp Müller, Kea Martin, Sebastian Theurich, et al.
Chemical Biology & Drug Design|May 15, 2023
Optimized synthesis, polymer conjugation, and proof-of-concept studies of the gd-IgA1 epitope for antibody-scavenging therapies in IgA nephropathyClément Bechtler, Ouliana Barneoud-Rousset, Lijuan Pang, et al.
Cancer Immunology, Immunotherapy : CII|June 8, 2014
The microtubule-depolymerizing agent ansamitocin P3 programs dendritic cells toward enhanced anti-tumor immunityKea Martin, Philipp Müller, Jens Schreiner, et al.
Science Translational Medicine|November 27, 2015
Trastuzumab emtansine (T-DM1) renders HER2+ breast cancer highly susceptible to CTLA-4/PD-1 blockadePhilipp Müller, Matthias Kreuzaler, Tarik Khan, et al.
JCI Insight|February 14, 2020
Immune cell landscaping reveals a protective role for regulatory T cells during kidney injury and fibrosisFernanda do Valle Duraes, Armelle Lafont, Martin Beibel, et al.
Cancer Immunology Research|June 12, 2014
Microtubule-depolymerizing agents used in antibody-drug conjugates induce antitumor immunity by stimulation of dendritic cellsPhilipp Müller, Kea Martin, Sebastian Theurich, et al.
Oncogenesis|April 7, 2021
CARD10 cleavage by MALT1 restricts lung carcinoma growth in vivoLaura Israël, Anton Glück, Marjorie Berger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2019
Malt1 Protease Deficiency in Mice Disrupts Immune Homeostasis at Environmental Barriers and Drives Systemic T Cell-Mediated AutoimmunityKea Martin, Ratiba Touil, Yeter Kolb, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|October 21, 2015
Modulation of APC Function and Anti-Tumor Immunity by Anti-Cancer DrugsKea Martin, Jens Schreiner, Alfred Zippelius
Neurology(R) Neuroimmunology & Neuroinflammation|November 11, 2021
Decrease in Serum Anti-MAG Autoantibodies Is Associated With Therapy Response in Patients With Anti-MAG Neuropathy: Retrospective StudyPascal Hänggi, Butrint Aliu, Kea Martin, et al.
Oncoimmunology|January 23, 2015
Cancer chemotherapy agents target intratumoral dendritic cells to potentiate antitumor immunityPhilipp Müller, Kea Martin, Sebastian Theurich, et al.
Chemical Biology & Drug Design|May 15, 2023
Optimized synthesis, polymer conjugation, and proof-of-concept studies of the gd-IgA1 epitope for antibody-scavenging therapies in IgA nephropathyClément Bechtler, Ouliana Barneoud-Rousset, Lijuan Pang, et al.
Cancer Immunology, Immunotherapy : CII|June 8, 2014
The microtubule-depolymerizing agent ansamitocin P3 programs dendritic cells toward enhanced anti-tumor immunityKea Martin, Philipp Müller, Jens Schreiner, et al.
Science Translational Medicine|November 27, 2015
Trastuzumab emtansine (T-DM1) renders HER2+ breast cancer highly susceptible to CTLA-4/PD-1 blockadePhilipp Müller, Matthias Kreuzaler, Tarik Khan, et al.
JCI Insight|February 14, 2020
Immune cell landscaping reveals a protective role for regulatory T cells during kidney injury and fibrosisFernanda do Valle Duraes, Armelle Lafont, Martin Beibel, et al.
Cancer Immunology Research|June 12, 2014
Microtubule-depolymerizing agents used in antibody-drug conjugates induce antitumor immunity by stimulation of dendritic cellsPhilipp Müller, Kea Martin, Sebastian Theurich, et al.
Oncogenesis|April 7, 2021
CARD10 cleavage by MALT1 restricts lung carcinoma growth in vivoLaura Israël, Anton Glück, Marjorie Berger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2019
Malt1 Protease Deficiency in Mice Disrupts Immune Homeostasis at Environmental Barriers and Drives Systemic T Cell-Mediated AutoimmunityKea Martin, Ratiba Touil, Yeter Kolb, et al.
Pageof 2